Skip to main content
. 2014 Jun 30;(6):1–110. doi: 10.1002/14651858.CD008152.pub3

Table 2.

AUC of gametocyte density over time, days 1 to 15 after treatment

Other malaria treatment type Trial Malaria treatment Dose PQ mg/kg AUC with PQ days 1 to 15 AUC without PQ days 1 to 15 % reduction AUC days 1 to 15 log(10)AUC with PQ days 1 to 15 log(10)AUC without PQ days1 to 15 % reduction log(10)AUC days 1 to 15
Non-artemisinin- based Kolaczinski 2012 a: CQ 0.5 485.26 4266.61 88.6 2.69 3.63 26.0

Kolaczinski 2012 b: SP 0.5 924.87 5964.77 84.5 2.97 3.78 21.4

Artemisinin- based Shekalaghe 2007 AS+SP 0.75 40.15 65.06 38.3 1.60 1.81 11.6

Smithuis 2010 a: AS+AQ 0.75 140.35 428.51 67.3 2.15 2.63 18.4

Smithuis 2010 b: AL 0.75 196.24 242.86 19.2 2.29 2.39 3.9

Smithuis 2010 c: AS+MQ fixed 0.75 237.78 510.03 53.4 2.38 2.71 12.2

Smithuis 2010 d: AS+MQ loose 0.75 183.51 293.28 37.4 2.26 2.47 8.3

Smithuis 2010 e: DHAP 0.75 295.24 709.60 58.4 2.47 2.85 13.4

Sutanto 2013 DHAP 0.75 1252.48 2355.84 46.8 3.10 3.37 8.1

Vasquez 2009 AS+MQ 0.75 500.40 305.67 -63.7 2.70 2.49 -8.6